343 ETH (Benazepril 20 mg)
Pill imprint 343 ETH has been identified as Benazepril hydrochloride 20 mg.
Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; left ventricular dysfunction and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 343 ETH (Benazepril 20 mg)
- 20 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Ethex Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- carnauba wax
silicon dioxide colloidal
ferric oxide black
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54569-5669||A S Medication Solutions LLC (repackager)|
|66336-0691||Dispensing Solutions Inc. (repackager)|
|68071-0146||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
Benazepril hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...